Tracking the information about your manuscript
Communicate with the editorial office
Query manuscript payment status Edit officeCollecting, editing, reviewing and other affairs offices
Managing manuscripts
Managing author information and external review Expert Information Expert officeOnline Review
Online Communication with the Editorial Department
Progress in Hand, Foot and Mouth Disease Vaccine Development and Challenges in Clinical Evaluation
ZHANG Bin;HU Yanyun;ZHAO Fei;CHEN Qi;WU Ting;Hand, foot and mouth disease(HFMD), as one of the most common viral infectious diseases among children under 5 years of age in China, is mainly caused by species Enterovirus A, including EV-A71, CVA16, CVA6 and CVA10. In recent years, the widespread use of monovalent inactivated EV-A71 vaccines has led to marked drop in EV-A71-associated morbidity, severe cases and deaths. However, owing to the lack of crossprotection against other enterovirus types, the etiological spectrum of HFMD in China has gradually shifted toward non-EV-A71 types, with an increasing proportion of cases attributable to CVA6 and related types. Against this background, this review summarizes the evidence on the protective efficacy, immunogenicity, safety and real-world application of licensed monovalent inactivated EV-A71 vaccines, outlines the clinical development progress of multivalent HFMD vaccine candidates, and discusses key challenges in the clinical evaluation of HFMD vaccines in the context of the changing etiological spectrum, with the aim of providing a reference for future vaccine development and optimization of prevention and control strategies.
Isolation, Identification and Genetic Characterization of Enterovirus D68 in Guangdong Province, China, in 2024
ZENG Hanri;LONG Yong;ZHANG Wei;LIU Baoqin;LI Caixia;KE Bixia;LU Jing;LI Bosheng;Objective To investigate the prevalence and genetic characteristics of Enterovirus D68(EV-D68) infection among hand, foot, and mouth disease(HFMD) cases in Guangdong province in 2024. Methods Enterovirus-positive specimens that were negative for Enterovirus A71(EV-A71), Coxsackievirus A16(CVA16), and Coxsackievirus A6(CVA6) were collected from HFMD cases in 2024 for genotyping. EV-D68-positive specimens were inoculated into RD cells for virus isolation, followed by VP1 gene sequencing and genetic analysis. Results Among 705 HFMD cases positive for other enteroviruses, 7 were identified as EVD68-positive, and all were mild cases. These cases were distributed across three cities in Guangdong province, namely Zhongshan, Jieyang, and Yunfu, representing the Pearl River Delta, eastern Guangdong, and western Guangdong, respectively, and occurred during the summer and autumn months(April, May, and September). One EV-D68 strain was successfully isolated, yielding a positive isolation rate of 12.5%. Phylogenetic analysis showed that among the seven EV-D68 sequences from Guangdong Province, six belonged to subclade B3 and one belonged to subclade D3. These strains showed the highest nucleotide sequence identity with the 2024 epidemic strains from Shanghai, namely the B3 strain(PQ826417) and the D3 strain(PQ766584), with sequence similarities of 98.9% – 99.6% and 99.5%, respectively. The amino acid sequence similarity between the Guangdong EV-D68 strains identified in 2024 and the prototype strain Fermon ranged from 88.4% to 92.0%. Compared with earlier domestic and international reference strains, the subclade B3 showed five consistent amino acid substitutions in the VP1 region(I1L, E2D, T95A, T98A, and N143S), whereas the subclade D3 showed four consistent substitutions(T148M, A178G, T277A, and D297E). Some of these mutation sites were located in the BC loop or DE loop. Conclusion In 2024, EV-D68 was distributed relatively widely in Guangdong Province, with both B3 and D3 subclades detected, of which B3 was predominant. These strains were highly homologous to the epidemic strains circulating in Shanghai in 2024 and exhibited consistent mutations at key amino acid sites in VP1. These findings suggest that EV-D68 may have undergone biological changes and had the potential for broader transmission in 2024, highlighting the need for increased attention and strengthened surveillance.
Research Progress on the Interaction Mechanism between Enterovirus Infection and cGAS-STING-IFNs Signaling Axis
HUANG Luci;LI Fei;CHEN Xiangpeng;Enteroviruses(EVs) are single-stranded positive-sense RNA viruses belonging to the Picornaviridae family and Enterovirus genus. Because of their ability to infect people of all ages, EVs have become major pathogens that threaten the health of children, especially infants and preschool children, presenting the highest incidence. EV infection is associated with a wide spectrum of clinical manifestations, including hand, foot, and mouth disease, aseptic meningitis, encephalitis, and myocarditis. In severe cases, it may lead to neurological complications or even death. EV infections occur sporadically or in localized outbreaks around the world, and the innate immune responses triggered by these infections play an important role in restricting viral replication within the body. At present, the mechanisms underlying the interactions between EVs and host cell RNA recognition receptors have been extensively investigated. With the continuous advancement of related studies, the immunoregulatory roles of DNA recognition receptors in RNA virus infection have aroused increasingly more attention. In particular, the cGAS-STING-IFNs signaling axis, in which cyclic GMP-AMP synthase(cGAS) activates the downstream stimulator of interferon genes(STING) to induce the production of interferons(IFNs), has become a major focus of current research. This review summarizes the mechanisms underlying the interactions between EV infection and the cGAS-STING-IFNs signaling axis, in hope of providing a reference for further elucidating the interaction network between EVs and host innate immunity.
Prevention and Control Strategies for the Risk of Imported Nipah Virus Disease
WANG Huanyu;Nipah virus disease(NVD) is a highly fatal zoonotic disease caused by Nipah virus(NiV), with a case fatality rate of 40%-75%. NiV can spread through close contact and cause limited human-to-human transmission. The virus culture experiments must be conducted in biosafety level 4 laboratories. NiV has been listed by the World Health Organization as a priority pathogen. No indigenous case has been reported in China, but fruit bats exist in southern provinces, so both imported and local spillover risks remain. Based on recent prevention and control practice, this commentary summarizes the etiological and epidemiological features of NiV and the import risk to China. The key points and difficulties in surveillance, laboratory detection, specimen transport and case transfer, clinical treatment, and vaccine development were analyzed. Strategies for imported disease prevention and control with the goals of early surveillance, rapid diagnosis, reduce CFR(case fatality rate), and panic control were proposed. This article provids a reference for the prevention and control of highly fatal imported zoonotic diseases.
Diverse Spread Pathways of Nipah Virus: From Cross-species Spillover to Human-to-human Transmission
ZHU Yiyi;DONG Wenbin;MAO Shenghua;CHEN Jian;PAN Hao;Nipah virus(NiV) is an important emerging zoonotic virus with high case-fatality rate and a substantial public health threat. Unlike many emerging viruses, the epidemiological characteristics of NiV are not defined as a single mode of transmission, but instead a multi-pathway transmission pattern involving exposure associated with natural reservoirs, amplification through intermediate hosts, and human-to-human spread in specific settings. This article systematically reviews the ecological characteristics of NiV, the major pathways of cross-species spillover and human-to-human transmission, and the factors influencing these processes, while comparing regional differences in dominant transmission patterns. Outbreaks in Malaysia and Singapore were mainly characterized by transmission involving pigs as amplification hosts; in Bangladesh, direct spillover occurred primarily through food contaminated by fruit bats and was accompanied by limited human-tohuman transmission; and some outbreaks in India highlight the risk of secondary transmission in household and healthcare settings. The formation of NiV transmission pathways is not determined by a single factor, but results of combined effects, including viral characteristics, the ecology of natural and intermediate hosts, environmental changes, dietary and care giving behaviors, and the prevention and control capacity of the local healthcare systems. The prevention and control of NiV should follow the One Health approach, implement region-specific interventions targeting distinct transmission pathways, and continuously improve risk awareness and control strategies.
Advances in the Research of Animal-derived Bioactive Peptides against Flavivirus Infection
CHEN Xingyu;YANG Qing;SHI Guangbo;HOU Lijing;FU Jialei;Flaviviruses are a genus of Flaviviridae viruses including dengue virus(DENV), Zika virus(ZIKV), yellow fever virus(YFV), West Nile virus(WNV) and Japanese encephalitis virus(JEV). In the absence of an effective specific drug against most flavivirus infections, together with the poor prevention and treatment strategies subject to viral species, serotype diversity and host immune backgrounds, flaviviruses pose a major threat to global public health. Animal-derived bioactive peptides, with broad sources, diverse structures, and biological activities such as membrane interaction, enzyme inhibition and immune regulation, have become important resources for discovering antiviral lead compounds. This review systematically summarizes recent advances in anti-flavivirus research involving animal-derived bioactive peptides from snake venom, scorpion venom, spider venom, and amphibian skin secretions. The key antiviral mechanisms, as discussed in this review, may involve the disruption of viral envelopes, blockade of viral attachment and membrane fusion, inhibition of NS2B-NS3 protease and RNA replication, regulation of the IFN/AXL axis, and modulation of the endosome-lysosome microenvironment, with aims to provide references for the development of novel anti-flavivirus candidate molecules.
[Downloads: 27 ] [Citations: 0 ] [Reads: 14 ] HTML PDF Cite this article
Preparation and Evaluation of Candidate Standard Strain of Human Bocavirus 1
SONG Qinqin;LIU Xuan;ZHU Rundong;HAN Jun;Objective To prepare Human Bocavirus 1(HBoV1) national standard strain as corresponding virus strain resources support for the monitoring, prevention and control of Human Bocavirus. Methods An organoid technology was utilized to isolate Bocavirus from human airway epithelial(HAE) organoids. Based on the observation of virus morphology, whole genome sequence, MEGA11, and mycoplasma detection were established to evaluate the biological characteristics and stability of Human Bocavirus strain. Results Swallow swab samples, after the separation from HAE organoids, can destroy the epithelial layer of the organoids after virus infection under inverted microscope. Under the negative staining electron microscope,the virus particles were observed to be spherical, sized within 20 – 25 nm and without envelope. Through whole-genome sequencing and genome assembly with reference, the full length of the virus genome sequence was determined to be 5638 bp. Through phylogenetic tree analysis, it was confirmed that the virus strain was HBoV1. Conclusion The HBoV1 strain isolated in this experiment had typical HAE cytopathic effects and typical morphological structures. Because of its stable activity and clear genetic characteristics, this HBoV1 can be used as a candidate strain for application as a national standard strain, as well as possible follow-up reagent development and immune effect evaluation.
[Downloads: 24 ] [Citations: 0 ] [Reads: 14 ] HTML PDF Cite this article
Genetic Evolution and Cross-Species Spillover of Hantaviruses
GUO Xin;YANG Zhanqiu;XIONG Hairong;Hantavirus is an important zoonotic pathogen that can cause hemorrhagic fever with renal syndrome and Hantavirus cardiopulmonary syndrome. Its genetic diversity, host switching and cross-species spillover jointly affect viral emergence and public health risk. This review analyzed the relationship between genetic evolution and cross-species spillover of Hantavirus, summarized the evolutionary evidence for host-virus codifferentiation and cross-host jumping, and focuses on the potential effects of point mutations, genetic reassortment, and homologous recombination on viral diversity and host adaptation. The host restrictions for cross-species infection were further discussed in terms of receptor recognition, innate immune evasion and intracellular replication. Based on these findings, a three-level funnel screening model was proposed to comprise pre-screening within natural hosts, spillover infection screening and secondary transmission screening in new hosts. The model integrated viral genomic data, animal exposure information and human transmission evidences. Current evidence indicated that most Hantaviruses can cause sporadic zoonotic infections, whereas reliable evidence of person-to-person transmission still mainly aimed at Andes virus. Climate change, host migration and human activities may further increase host contact and cross-regional spreading. This review provided a framework for Hantavirus monitoring, cross-species spillover risk assessment and source-oriented prevention of zoonotic diseases.
[Downloads: 23 ] [Citations: 0 ] [Reads: 11 ] HTML PDF Cite this article
Correlation between Serum HBV RNA Level and Liver Fibrosis Indicator and Systemic Immune Inflammation Index in Patients with Severe Hepatitis B
LAI Xiaoyan;CHEN Tangen;LIU Baoying;ZENG Shuyun;Objective To investigate the correlation between serum hepatitis B virus(HBV) RNA level and liver fibrosis index and systemic immune inflammation index(SII) in patients with severe hepatitis B. Methods The clinical data of 110 patients with severe hepatitis B admitted to the hospital from January 2023 to January 2026 were retrospectively included. According to the median of serum HBV RNA level at admission, the patients were divided into high-level group and low-level group. Comparison was made to the differences of liver fibrosis and SII related indicators in patients with different levels of serum HBV RNA. According to the liver stiffness measurement(LSM), patients with severe hepatitis B were divided into liver fibrosis group and cirrhosis group, and the serum HBV RNA levels were compared between the two groups. The correlation between serum HBV RNA level and liver fibrosis index and SII in patients with severe hepatitis B was analyzed by bivariate Pearson, and the relationship between serum HBV RNA level and cirrhosis in patients with severe hepatitis B was evaluated by Logistic regression model. Results The liver stiffness of the high-level group is greater than that of the low-level group(P < 0.05). The serum neutrophil count, ALT, AST, TBiL, HBsAg and HBV DNA quantification in the high-level group are higher than those in the lowlevel group, and the PTA of the high-level group is lower than that in the low-level group(P < 0.05). The serum LN, HA, PIIINP, IV-C and SII in the high-level group are higher than those in the low-level group(P < 0.05). By bivariate Pearson correlation analysis, serum HBV RNA level is positively correlated with liver fibrosis indicators(LN, HA, PIIINP, IV-C) and SII(r > 0, P < 0.05). By constructing the logistic regression model, the results show that serum HBV RNA level increases and the risk of cirrhosis in patients with severe hepatitis B increases without adjusting any independent variables. After adjusting all independent variables, the risk of cirrhosis in patients with high serum HBV RNA levels is significantly increased(P < 0.05). Conclusion Serum HBV RNA levels are associated with liver fibrosis indicators and SII in patients with severe hepatitis B. With the increase of serum HBV RNA levels, the risk of cirrhosis and inflammatory response in patients with severe hepatitis B also increase.
[Downloads: 39 ] [Citations: 0 ] [Reads: 11 ] HTML PDF Cite this article
Clinical Characteristics, Laboratory Indicators and Prognostic Analysis of Diseases Related to EB Virus Infection in Children
XIA Meimei;YANG Chunhua;TANG Changkui;Objective To explore the clinical characteristics, laboratory indicators, diagnosis and treatment strategies, and prognosis of children with diseases related to Epstein-Barr virus(EBV) infection, and to provide a basis for standardized clinical diagnosis and treatment in pediatrics. Methods A retrospective cohort study was conducted to collect the clinical data of children diagnosed with diseases related to EBV infection in the pediatric department of a hospital from January 2021 to December 2024. The children were divided into infectious mononucleosis(IM) group, EBV-related respiratory infection group, EBV-related liver injury group, and chronic active EBV infection/severe EBV infection group based on the disease spectrum. Besides, comparison was made to the general conditions, clinical manifestations, laboratory results, treatment plans, and prognosis of each group. Results A total of 186 children were included, including 104 males and 82 females, with the age ranged from 1 year and 2 months to 14 years. There were 92 cases in the IM group, 48 cases in the EBV-related respiratory infection group, 31 cases in the EBV-related liver injury group, and 15 cases in the chronic active EBV infection/severe EBV infection group. Fever, angina, and cervical lymph node enlargement were common manifestations. Hepatomegaly and splenomegaly were more common in the IM group and severe group. The proportion of atypical lymphocytes in peripheral blood, EBV-DNA load, ALT, AST, LDH, and ferritin levels were significantly increased in the severe group, and the proportion of concurrent blood cell reduction, coagulation abnormalities, and multi-system involvement was higher. Most children with common EBV infection recovered well after symptomatic and supportive treatment; some children in the severe group received glucocorticoid, gamma globulin, and individualized immunomodulatory therapy, with prolonged hospital stay, higher risk of recurrence and protracted course. Conclusion The clinical spectrum of children with diseases related to EBV infection is wide. Mild cases may present as self-limiting infectious mononucleosis, while severe cases may progress to chronic active EBV infection and multi-organ damage. EBV-DNA quantitation, liver function, inflammatory indicators, and blood routine monitoring are of great value for disease assessment. Early identification of severe high-risk children and implementation of stratified diagnosis and treatment, as well as multidisciplinary collaborative management, are helpful to improve the prognosis.
[Downloads: 23 ] [Citations: 0 ] [Reads: 12 ] HTML PDF Cite this article
Isolation of Subgroup J Avian Leukosis Viruses and Their Partial Sequence Comparison
DU Yan 1, CUI Zhi zhong 1,2 , QIN Ai jian 1, Silva R. F. 3, Lee L. F. 3 (1.Department of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China; 2. College of Animal Science, Shandong Agricultural University, Taian 271018, China; 3.Subgroup J avian leukosis viruses (ALV J) were isolated from two broiler breeder farms with suspected diseased chickens and two commercial broiler flocks without clinical symptoms by inoculating the samples into chicken embryo fibroblast cells and PCR amplification of the infected CEF genomic DNA. In the indirect fluorescence assay (IFA) with ALV J specific monoclonal antibody JE9, 2 strains, SD9901 and SD9902 from breeder with suspected lesions, were strongly positive, another 2 strains, YZ9901 and YZ9902 from commercial broilers without clinical symptoms gave weak reactions. The genomes of strains YZ9901 and SD9902 were partially sequenced and the results indicated that their gp85 had 89%-93% identity in the amino acid level with ALV J prototype HPRS 103 and American strain ADOL HCl. The amino acid identity among themselves was 92%. The 3' noncoding LTR region had 95%-97% identity in the nucleotide level with ALV J prototype strain HPRS 103. But the Chinese strains had a 139 base deletion mutation in their E elements nearby the 3' LTR region and got an insertion of 11 base fragment instead.
CONSTRUCTION AND APPLICATION OF A HIGH LEVEL EXPRESSION VECTOR CONTAINING P_RPL PROMOTER
Zhang Zhiqing Yao Lihong Hou Yunde(National Laboratory of Molecular Virology and Genetic Engineering, Institute of Virology, Chinese Academy of Preventive Medicine, Beijing )A high level expression vector has been constructed,which contains PR PL promoter, cIts857 gene, multiple cloning sites ( MCS ) and two strong transcription terminators. Foreign gene with ATG signal can be inserted into the MCS, expressing non-fusion protein. Using this vector, we have expressed successfully the human interferon r,human interleukin-2 and human tumor necrosis factor. The foreign gene product accounts for more than 20% of the total cell protein.
NORWALK-LIKE VIRUS INFECTION FOUND IN DIARRHEA PATIENTS IN CHINA
Fang Zhaoyin Wen Leying Jin ShengJin Zhao Zhanghua C. Moe H. Yoshikura R.Glass(Institute of Virology,CAPM ,Beijing 100052) 1.Henan Institute of Traditional Chinese Medicine; 2.Centers for Disease control and prevention,USA; 3.University of Tokyo,JapanNorwalk virus or Norwalk virus -like agents are important pathogens that causeoutberaks of acute nonbacterial gastroenteritis. Two Norwalk-like virus isolates were identifiedin fecal specimens from acute diarrhea patients in Henan province during Oct.1990-Jan1991 rotavirus season by electron microscopy that shows 28nm diameter with structured capsid.RT-PCR using Norwalk -specific primer pair 51-3,and nucleotidesequencing of PCR products showed 72%homology of these two isolates to that of Norwalkvirus prototype 8FⅡa. Our finding suggests that more attention should be pai to outbreaks of acute gastroenteritis caused by Norwalk-like virus in China.
Identification of a New Subgroup of Avian Leukosis Virus Isolated from Chinese Indigenous Chicken Breeds
WANG Xin,ZHAO Peng,CUI Zhi-zhong(College of Veterinary Medicine,Shandong Agricultural University,Tai an 271018,China)In order to clarify Avian leukosis virus(ALV) characteristics from Chinese native chicken breeds,three ALV JS11C1,JS11C2 and JS11C3 were isolated from Chinese native breed "luhua" by inoculation of DF1 cell culture and detection of p27 antigen.Using PCR amplification of env gene,the amplified gp85 genes were analyzed and compared to all six chicken ALV subgroups reported.The gp85 genes of these three viruses were 1 005bp in length and encoded 335 amino acids,and the gp37 genes were 609bp and encoded 203 amino acids.The homology of gp85 among these three isolated strains was 91.9%-97.0%.Comparing to 18 stains of subgroup A,B,C,D,E published in GenBank,the homology was only in the range of 77.7%-84.6%,significantly lower than the gp85 homology observed within the common chicken subgroups A(88.2%-98.5%),B(91.6%-98.8%),and E(97.9%-99.4%).The gp85 homology compared with subgroup J was only 34.2%-36.5%.These results suggested that three isolated strains from Chinese native breed "luhua" belong to a new subgroup different from all six known subgroups from Chickens,and thus designated as subgroup K.
[Downloads: 1,120 ] [Citations: 227 ] [Reads: 406 ] HTML PDF Cite this article
Identification of Enterovirus Type 71 by RT-PCR and the Gene Characterization
CUI Ai-li~ 1, XU Wen-bo~ 1, LI Xiu-zhu~ 2, HU Jia-yu~ 2, LING Hua~ 3, TANG Wei~ 2, YANG Zhi-hong~ 4, ZHANG Yan~ 1, CHEN Li~ 1, Hiroyuki Shimizu~ 5(1. National Institute for Viral Disease Control and Prevention, China CDC, Beijing 100052, China;2. Shanghai Center for Disease Control and Prevention, Shanghai 200336, China;3. Chongqing Center for Disease Control and Prevention, Chongqing 400042, China;4. Childrens Hospital, Fudan University, Shanghai 200032, China;5. National Institute of Hygiene, Japan)10 virus strains were isolated from clinical specimens of children with hand-foot-and-mouth disease (HFMD), 9 isolates from Shanghai and 1 isolate from Chongqing. All of the 10 isolates were tested by RT-PCR assay with two specific primer pairs for VP1 genes of enterovirus type 71 (EV71) and Coxsackie virus A16 (Cox. A16) respectively. The enterovirus serotype 71 and Cox. A16 were primarily identified depending on the size of PCR products and the primers used. The RT-PCR results indicated that 2 EV71 isolates were from Shanghai, 1 was from Chongqing and 7 Cox. A16 isolates were from Shanghai. All of the 10 PCR products were sequenced, the sequence analysis confirmed that PCR identified results was 100% correlative to virus sequencing, so RT-PCR assay is highly specific and probably may be the first choice for identification of EV71 and Cox. A16. 891 nucleotides of VP1 coding genes of 3 EV71 isolated strains were sequenced and compared with that of previously isolated 7 EV71 Chinese isolates available from GenBank (SHZH03?SHZH98?SH-F1?SH-F2?SH-H25?SH-H26 and CHN-87) by homogeneity and phylogenetic tree analyses. The homogeneity of these 10 Chinese strains with the representative isolates of C genotype of EV71 was between 89.3%-94.6%; with the representative isolates of A and B genotypes was between 81.3%-84.0%. The data suggested that all of the 10 Chinese isolates belong to EV71 genotype C except CHN-87, which was untyped. The homogeneity of the 3 EV71 isolated strains and 6 previously isolated strains (SHZH03?SHZH98?SH-F1?SH-F2?SH-H25?SH-H26) were between 94.5%-100%, that formed a single branch in the phylogenetic tree. There were only 89.3%-92.9% homology among these 9 strains and the representative strains of C1?C2?C3 sub-genotypes of EV71, this suggested that these 9 Chinese isolates and the TAI-98 composed a new sub-genotype, the C4 sub-genotype, of the C genotype. EV71 of sub-genotype C4 distributed in Shenzhen, Chongqiang and Shanghai from 1988-2003. It is much helpful to develop EV71 diagnosis, virus surveillance, virus standard nomenclature and set up EV71 virus bank and virus gene bank to accelerate the control and prevention of EV71 outbreak in China and in the world.
Research Progress on the Infection Mechanism of Coronavirus SARS-CoV-2
LU Rongguang;WU Jing;BAI Xue;LIU Weiquan;An emerging infectious disease COVID-19 which caused by a novel coronavirus SARS-CoV-2,has spread to many countries and regions around the world. For now,COVID-19 triggered a global public concern about healthy safety. Although just about 2% SARS-CoV-2 infected patients have contacted with wild animals,most scientists still believe that SARS-CoV-2 origin from wild animals. In fact,virus interspecies transmission is very difficult and lead to the new host dead in most cases. However,different from the other viruses,SARSCoV-2 have adapt to human body very well since SARS-CoV-2 emerged. Thus,we reviewed several research advances about etiology,function receptor and evolution of SARS-CoV-2,try to provide a new perspective to understand the emergence of SARS-CoV-2.
Prediction of the Epidemic Trend of COVID-19
YAN Mingjiang;DONG Yihong;JIA Xiangen;ZHENG Haiyang;XIN Yu;Coronavirus disease 2019(COVID-19) spread initially from Wuhan(Hubei Province,China) in December 2019 through China,but is now a pandemic. Unprecedented steps have been taken throughout China to vigorously carry out disease treatment and epidemic prevention. Official statistics published by the National Health Commission of the People's Republic of China were collected to predict the trend of the epidemic. In the traditional Susceptible,Exposed,Infectious,Recovered(SEIR) model,only infectious patients and noninfectious latent patients are considered. However,COVID-19-diagnosed patients cannot infect the susceptible population because they have been isolated in hospitals,whereas latent patients may be infectious. Based on this information,we propose an improved model of infectious-disease transmission:"ISEIR". In ISEIR,patients are divided into outpatients(with infectivity)and inpatients(infectivity is not considered). Preclinical patients who are infectious are also considered. ISEIR fits model parameters dynamically with historical data to exclude the limitations of fixed parameters. The data of patients diagnosed early with COVID-19 in Hubei Province,China was seriously distorted. Therefore,according to the probability distribution of the daily basic reproduction number(R0),the clinical-diagnosis data of February 12–14 were preprocessed and spread into previous data to correct distortion of previous data. The epidemic situation was divided into two regions:the whole country(excluding Hubei Province,China)and Hubei Province,China. The new ISEIR predicts further development of the future epidemic,and calculates the change in daily R0. Results revealed that the R0 of Hubei Province,China has reduced gradually from 3.108. All patients will be cured and discharged from hospital around April 19.The initial R0 of China(excluding Hubei Province)was 1.929,and all patients will be cured around March 26.Results showed that the epidemic has been suppressed effectively under strict prevention-and-control measures.It is also necessary to prevent rebound of the epidemic situation caused by the resumption of employment.
Research Progress in Novel Coronavirus(2019-nCoV)-Related Drugs In Vitro and In Vivo
SONG Gao;CHENG Mengqun;WEI Xianwen;In December 2019 in Wuhan City(Hubei Province,China),multiple cases of patients with pneumonia infected by a new type of coronavirus were noted. With the spread of the epidemic,other cases in China and overseas have also been found. On 12 January 2020,the World Health Organization tentatively named it"2019 Novel Coronavirus"(2019-nCoV). This is a new type of virus,which is highly infectious and can cause severe respiratory diseases. A clinically efficacious treatment is lacking. We reviewed the guidelines for recommended therapeutic drugs and drug-development advances with the aim of providing a reference for clinical treatment of 2019-nCoV infection.
Research Progress on SARS-CoV-2
XIE Qian;WU Zhengyu;SHU Yuelong;Since December 2019,the outbreak of coronavirus disease 2019(COVID-19)in Wuhan,China,has spread rapidly to other provinces and cities in China,and worldwide. Severe acute respiratory syndrome(SARS)-CoV-2 belongs to the β-coronavirus family,which is closely related to SARS-CoV and Middle East respiratory syndrome(MERS)-CoV,but quite different,especially in the spike protein. SARS-CoV-2 may be derived from bats according to sequence comparison. SARS-CoV-2 uses the same receptor,angiotensin converting enzyme Ⅱ(ACE2),as SARS-CoV. The main transmission routes include droplets and close contacts. The lack of effective drugs and vaccine is a challenge for outbreak control.
Research Progress of the Molecule Mechanisms of Ebola Virus Infection of Cells
SHI Ming,SHEN Yu-qing(Medical School of Southeast University,Nanjing 210009,China)Ebola virus can cause severe Ebola hemorrhagic fever.The mortality rate is 90 percent.Up till now,there is no effective vaccine or treatment of Ebola virus infection.Relaed researches on Ebola virus have become a hot topic in virology.The understanding of molecular mechanisms of Ebola virus infection of cells are important for the development of vaccine and anti-virus drugs.Therefore,this review summarized the recent research progress on the mechanisms of Ebola virus infection.
Announcement
Page Views
Page visits today: 863